TLR4 and Sepsis: Therefore, it can be suggested that isorhamnetin binds to MD-2, resulting in the inhibition of the TLR4/MD-2 dimerization, which may eventually downregulate the activation of TLR4 pathway-induced inflammation and sepsis.